2007 Office systemとは 意味・読み方・使い方

The Ministry of Economy, Trade and Industry (Japan Patent Office) formulated the Advanced Measures for Accelerating Reform toward Innovation Plan in Patent Examination (AMARI Plan 2007)68 in January 2007. This plan is composed of four areas and 26 items covering efforts to develop and strengthen the intellectual assets system, such as closer cooperation with foreign patent offices, promotion of international harmonization of systems, promotion of global rights acquisition and stronger intellectual assets protections by stronger counterfeit goods countermeasures, etc., faster and more efficient examinations by the patent office, promotion of strategic intellectual assets management in companies, stronger support for utilization of intellectual assets of the regions and in medium and small companies, etc例文帳に追加

経済産業省（特許庁）は、2007 年1月、外国特許庁との協力強化、制度の国際調和の推進、模倣品対策の強化等によるグローバルな権利取得の促進と知的財産保護の強化、特許庁による審査迅速化・効率化、企業における戦略的な知的財産管理の促進、地域や中小企業の知的財産活用に対する支援の強化等の4分野26項目からなる「イノベーション促進のための特許審査改革加速プラン2007（AMARIプラン2007）28」を策定し、知的財産制度の整備・強化のための取組を行っている。 - 経済産業省

The Treasury Department Report released in December 2007 describes more specific proposals based on the aforementioned committee report. For example, it proposes that the income subject to the extraterritorial income exclusion system should be the dividend income and the branch office profit, and offers an alternative proposal for expanding the scope of the exemption to the interest/usage fees.例文帳に追加

続いて、2007年12月に公表された米国財務省報告書においては、更にこれを具体化した提案がなされており、国外所得免除方式の対象所得を配当所得と支店利益としつつ、代替案として、免除対象を利子・使用料に拡大する等の案が例示されている。 - 経済産業省

The above mentioned items were also included as one of the goals in the "5-Year Strategy for the Creation of Innovative Pharmaceuticals and Medical Devices" (April 2007 Cabinet Office, Ministry of Education, Culture, Sports, Science and Technology, Ministry of Health, Labour and Welfare, and the Ministry of Economy, Trade and Industry) so that Japan, which has few natural resources, use its superior research and development abilities to participate in the global development and provision system of innovative pharmaceuticals and medical devices as well as expand the share of innovative pharmaceuticals and medical devices developed in Japan in the global market, thereby allowing the pharmaceutical and medical device industry to drive Japan's growth. Measures for the development of the clinical trial and clinical research environment required to realize this goal were set forth, and this 5-Year Plan plays an important part of these measures.例文帳に追加

上記の事項は、「革新的医薬品・医療機器創出のための５か年戦略」（平成19 年4 月 内閣府・文部科学省・厚生労働省・経済産業省）においても、天然資源の少ない我が国が、優れた研究開発力をもとに、革新的医薬品・医療機器の国際的開発・提供体制へ参加していくとともに、日本で開発される革新的医薬品・ 医療機器の世界市場におけるシェアを拡大することで、医薬品・医療機器産業を日本の成長牽引役へ導くことが目標のひとつとされ、その実現のために臨床研究・治験環境の整備を施策に掲げ、この５カ年計画がその施策の重要な部分を担っていることを示している。 - 厚生労働省